High voltage activated calcium channels are hetero-oligomeric protein complexes that mediate multiple cellular processes including the influx of extracellular Ca 2+ , neurotransmitter release, gene transcription and synaptic plasticity. These channels consist of a primary α1 pore-forming subunit, which is associated with an extracellular α 2 δ subunit and an intracellular β auxiliary subunit, which alter the gating properties and trafficking of the calcium channel. The cellular localization of the α 2 δ 3 subunit in the mouse and rat retina is unknown. In this study, using RT-PCR a single band at ~305 bp corresponding to the predicted size of the α 2 δ 3 subunit fragment was in mouse and rat retina and brain homogenates. Western blotting of rodent retina and brain homogenates showed a single 123 kDa band. Immunohistochemistry using an affinity purified antibody to the α 2 δ 3 subunit revealed immunoreactive cell bodies in the ganglion cell layer (GCL) and inner nuclear layer (INL), and immunoreactive processes in the inner plexiform layer (IPL) and the outer plexiform layer (OPL). α 2 δ 3 immunoreactivity was localized to multiple cell types, including ganglion, amacrine and bipolar cells, and photoreceptors, but not by horizontal cells. The expression of the α 2 δ 3 calcium channel subunit to multiple cell types suggests this subunit participates widely in Ca channel-mediated signaling in the retina.
Introduction
High voltage activated (HVA) calcium channels are transmembrane proteins comprised of an α1 subunit that contains the channel pore and voltage-sensor, and α 2 δ and β auxiliary subunits (reviewed in Catterall, 2000) . The α1 subunits establish the biophysical and pharmacological properties of the calcium channel (Catterall, 2000) . The α 2 δ genes (CACNA2D1-4) encode four different α 2 δ subunits, α 2 δ 1 -α 2 δ 4 (Klugbauer et al., 1999) . The predominantly, extracellular α 2 δ subunits regulate plasma membrane trafficking and expression of the α1 subunit as well as altering the biophysical properties of the channel (reviewed in Davies et al., 2007; Bauer et al., 2010; Dolphin, 2012) .
The α 2 δ subunits are expressed differentially in the brain (Klugbauer et al., 1999; Barclay et al., 2001; Brodbeck et al., 2002; Cole et al., 2005) and retina (Nakajima et al., 2009; Huang et al., 2013; Pérez de Sevilla Müller et al., 2013) . α 2 δ 1 mRNA is reported in mouse cerebellar, hippocampal and cortical extracts (Klugbauer et al., 1999; Cole et al., 2005) . In the central nervous system (CNS), α 2 δ 1 subunit immunoreactivity is observed at all levels of the neuroaxis, including the spinal cord, brain stem, thalamus and forebrain (Taylor and Garrido, 2008) . In hippocampus, α 2 δ 1 subunit immunostaining is heterogeneous with a greater density in areas having glutamate terminals (Taylor and Garrido, 2008) . In the rat retina, the majority of ganglion cells, as well as amacrine, bipolar and horizontal cells express the α 2 δ 1 subunit (Huang et al., 2013) . In addition, Müller cells and astrocytes express the α 2 δ 1 subunit (Huang et al., 2013) . In the mouse and rat CNS, α 2 δ 2 mRNA is strongly expressed in cerebellar Purkinje cells and in interneurons of the cortex, hippocampus and striatum (Barclay et al., 2001; Brodbeck et al., 5 as a tumor suppressor gene in human gastric cancer cells (Wanajo et al., 2008) . The α 2 δ 4 subunit is expressed in non-neuronal endocrine cells (Arikkath and Campbell, 2003; Klugbauer et al., 2003) . Recently, we reported α 2 δ 4 mRNA in mouse and rat CNS and retina; α 2 δ 4 subunit immunostaining was present in Müller cells and a few displaced ganglion cells, as well as ON bipolar cell dendritic tips and photoreceptor terminals (Pérez de Sevilla Müller et al., 2013) . α 2 δ 4 subunit immunoreactivity has also been localized to salamander photoreceptor terminals (Mercer et al., 2011) . Interestingly, a mutation in the Cacna2d4 gene has been implicated in a novel conerod retinal disease in mouse (Ruether et al., 2000; Wycisk et al., 2006a, b) .
The goal of the present study was to establish the expression and cellular localization of the α 2 δ 3 subunit in rat and mouse retina. α 2 δ 3 mRNA was detected in retina and brain by RT-PCR and a single band corresponding to the predicted size of the α 2 δ 3 subunit was detected in retina and brain extracts on Western blots. Cell bodies in the ganglion cell layer (GCL) and inner nuclear layer (INL) contain α 2 δ 3 subunit immunoreactivity, and processes in the inner plexiform layer (IPL) and puncta in the outer plexiform layer (OPL) have strong α 2 δ 3 subunit immunoreactivity.
Double-label immunostaining experiments demonstrated the expression of α 2 δ 3 subunit in all retinal cell types except Müller and horizontal cells. These findings suggest that the α 2 δ 3 subunit has a broad influence in the retina, and mediates HVA channel properties that would affect intracellular signaling pathways, neurotransmitter release, neuronal excitation, synaptic stabilization and synaptogenesis (Arikkath and Campbell, 2003; Dickman et al., 2008; Eroglu et al., 2009; Kurshan et al., 2009 ).
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Methods and Materials
Animal preparation: All experiments were carried out in accordance with the guidelines for the welfare of experimental animals issued by the U.S. Public Health Service Policy on Human Care and Use of Laboratory Animals and the University of California-Los Angeles (UCLA) Animal
Research Committee. Adult Sprague-Dawley rats (100-300 g, Charles River, Wilmington, MA, RRID:RGD_734476), and wild-type C57BL/6 mice (20-30 g; Jackson Laboratory, Bar Harbor, ME, RRID:IMSR_JAX:000664) of both sexes were used for these studies. Animals were 2-3 months old at the time of the experiments.
Animals were deeply anesthetized with 1-3% isoflurane (Abbott Laboratories, North Chicago, IL), and killed by decapitation or cervical dislocation. The eyes were removed and dissected in Hibernate A (Invitrogen, Carlsbad, CA). For vertical cryosections of the retina, the eyecups were fixed in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB), pH 7.4, for 15-60 minutes at room temperature (RT). Eyecups were then transferred to 20% sucrose in PB for an hour or 30% sucrose in PB overnight at 4°C. The eyecups were embedded in optimal cutting temperature medium (Sakura Finetek Inc., Torrance, CA) and sectioned at 12-14 µm using a Leica CM3050S or Leica CM 1900 cryostat (Leica Microsystems, Buffalo Grove, IL) and tissue sections were mounted onto gelatin-coated slides. Sections were stored at -20 o C until immunostaining.
Whole-mount immunostaining:
Retinas were dissected from the eyecup and mounted on cellulose filter paper (EMD Millipore, Temecula, CA) with the GCL up and fixed in 4% PFA for 10 minutes. The whole-mounted retinas were then washed in PB three times for a total of 90 minutes and incubated in 10% normal goat serum at 4°C overnight. The retinas were subsequently incubated in primary antibody (see Table 1 ) for 5-7 days at 4°C and washed three times for a total of 90 minutes in 0.1 M PB. The retinas were placed in the appropriate secondary antibody overnight at 4°C. After three washes for a total of 90 minutes in PB, the retinas were mounted in Vectashield Mounting Medium (Vector Laboratories, Burlingame, CA). Coverslips were sealed with nail polish. Slides were stored at 4°C and protected from light.
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Immunostaining of cryosections of the retina: Retinal sections were incubated in 10% normal donkey serum (NDS) or normal goat serum (NGS) diluted 1:15 in PB with 0.3-0.5% Triton X-100 for 1-2 hours at RT. Sections were then placed in the primary antibody (see Table 1 ) diluted in PB with 0.3-0.5% Triton X-100 and 0.1% NaN 3 overnight at 4°C. After the primary incubation, the sections were washed three times for a total of 30 minutes in PB and placed in their corresponding secondary antibodies, Alexa Fluor 488-, 555-or 594-rabbit IgG, Alexa Fluor 555-mouse IgG, Alexa Fluor 546-goat IgG, Alexa Fluor 488-rat IgG (Invitrogen) at 1:500-1:1000 dilutions for 2 hours at RT. After a final wash for a total of 30 minutes, the sections were mounted in Vectashield (Vector Laboratories, Burlingame, CA), Aqua Poly/Mount mounting medium (Polysciences, Inc., Warrington, PA) or Citifluor (Citifluor Ltd; London, UK).
To evaluate the specificity of the primary antibody immunostaining, a preadsorption control was performed. Briefly, the α 2 δ 3 antibody was diluted in 0.1 M PB containing 0.3% Triton X-100 with a Protein Epitope Signature Tag (PrEST) antigen of human Cacna2d3 (Atlas Antibodies AB, Stockholm, Sweden) at a final concentration of 1 µg/ml for 12 hours at RT. This antigen is fused to a dual tag consisting of the His6 tag and albumin-binding protein. The antibodies directed against the dual tag were depleted before capturing the antigen (Cacna2d3)-specific antibodies in a separate purification step (manufacture's datasheet). No immunostaining was present in sections incubated with the preabsorbed α 2 δ 3 subunit antibody, demonstrating the specificity of the antibody (see Results). Except for the α 2 δ 3 subunit antibody, all the antibodies employed in this study have been used previously with paraformaldehyde-fixed tissue; our immunostaining patterns were identical to those previously reported earlier ( manufacturer's datasheet). The specificity of this calbindin antibody has been documented previously and it has been used to identify horizontal cells in the rodent retina (Peichl and González-Soriano, 1994; Haverkamp and Wässle, 2000; Hirano et al., 2011) .
A goat polyclonal affinity-purified antibody to Chx10 (cat. #sc-21690; Santa Cruz Biotechnology, clone: N-18, Santa Cruz, CA, RRID:AB_2216006) was raised against a peptide corresponding to human Chx10 44-61 (PPSSHPRAALDGLAPGHL). The Chx10 antibody detects a single 46 kDa band on a Western blot of mouse eye extracts corresponding to the predicted size of Chx10 (manufacturer's datasheet). Chx10 recognizes bipolar cells and a subset of Müller cells in the retina (Liu et al., 1994; Rowan and Cepko, 2004; Elshatory et al., 2007; Whitaker and Cooper, 2009 (Schmitz et al., 2000; tom Dieck et al., 2005; Jusuf et al., 2006; Puller et al., 2007) .
A mouse monoclonal antibody to GAD 67 (cat. #MAB5406; EMD Millipore,RRID:AB_2278725) detected a single band at 67 kDa on Western blots of rat cortex (Erlander et al., 1991) . This antibody does not cross-react with the GAD 65 isoform in a Western blot of rat cortex (Fong et al., 2005) . In addition, immunostaining in the brain showed an overall decrease in a conditional GAD 67 knockout mutant (Heusner et al., 2008) . The antibody stains GABA immunoreactive amacrine cells in the retina (Guo et al., 2010; Delgado et al., 2009) .
A rat polyclonal antibody to glycine (cat. #IG1002, ImmunoSolution, Queensland, Australia, RRID:AB_10013222) detected by dot blotting the same amino acid-PFA-thyroglobulin conjugate that was used to immunize the animals. This antibody detected on dot blots conjugates containing glycine, but not conjugates with related amino acids (Pow et al., 1995) .
Immunostaining was absent following preabsorption with a PFA conjugate of glycine and thyroglobulin (Pow et al., 1995) . This antibody selectively immunostains amacrine cells in the retina of multiple species, including mouse and rat (Pow and Hendrickson, 1999; Haverkamp and Wässle, 2000 (Young et al.,1988) . PKC is a marker for rod bipolar cells in the mouse and rat retina (Haverkamp and Wässle, 2000; Ghosh et al., 2001; Haverkamp et al., 2003) .
Immunostaining was completely eliminated by the full-length peptide, but was not by unrelated peptides (Young et al., 1988) . A guinea pig polyclonal antibody to the vesicular glutamate transporter 1 (VGluT1) (cat.
#AB5905; EMD Millipore, RRID:AB_2301751) recognizes a single band of the expected molecular size of 62 kDa on Western blots of rat hippocampal membranes (McIntire et al., 1997; Sagné et al., 1997; Pacheco Otalora et al., 2006) and immunostains photoreceptor and bipolar cell axon terminals in mouse retina (Bellocchio et al.,1998; Sherry et al., 2003) . Preadsorption of the VGluT1 antiserum with the peptide used for the immunization eliminates specific immunostaining (Fyk-Kolodziej et al., 2004) . Immunostaining was completely absent in retinae of VGluT1 null mice (Johnson et al., 2007) .
RT-PCR:
Total RNA was isolated from mouse and rat retina and brain homogenates using Expected fragment size was 305 bp.
PCR was performed in a 20 µl reaction volume containing 0.25 µM of each primer, 0.1 units/µl of EconoTaq DNA Polymerase, 400 µM dATP, 400 µM dGTP, 400 µM dCTP and 400 µM dATP, 3 mM MgCl 2 (Lucigen Corporation, Middleton, WI, USA) with 2 µl (1/10th) of the cDNA synthesis reaction as template. The following temperature protocol was used: 2 minutes at 96°C, 35 cycles of 30 seconds at 95°C, 30 seconds at 55°C, 1 minute at 72°C, followed by a final extension of 5 minutes at 72°C. 5 µl of the PCR was electrophoresed on a 1.5% agarose gel in 1X TAE (40 mM Tris-acetate, 1 mM EDTA buffer). DNA was visualized using Gel Red
(1:10,000) (Biotium, Hayward, CA, USA).
Western Blots: Rodent retina and brain samples were isolated and placed immediately in dH 2 O containing 1.5M Tris-HCl, 0.5M EDTA, 0.5M EGTA and 20% Triton X-100 on dry ice. Six mouse retinas or four rat retinas were prepared together. Cell lysis buffer contained 10 µl/ml Halt Protease Inhibitor and 10 µl/ml Halt Phosphatase Inhibitor cocktails (Thermo Fisher Scientific, Waltham, MA, USA). Samples were homogenized for 2 minutes and incubated on ice for 20 minutes to lyse cells. After centrifugation (20,100xg; 30 minutes at 4°C), the supernatant fractions were removed. The NanoDrop Spectrophotometer (Thermo Fisher Scientific) was used to measure protein content of the samples. Protein samples were diluted in Laemmli sample buffer, pH 6.8, and samples were boiled for 10 minutes before loading onto the gel.
Western blot analysis of the homogenates was performed after fractionating 35 µg of protein by 4-20% SDS-PAGE (200V for 30 minutes) using Mini-PROTEAN ® TGX™ precast polyacrylamide gels (Bio-Rad Laboratories, Hercules, CA, USA). Pre-stained marker proteins were used as molecular mass standards. The separated proteins were transferred to PVDF Immobilon-FL membranes (EMD Millipore) by electroblotting at 360 mA for 2 hours at 4°C. Blots were allowed to dry completely to increase protein retention before blocking binding sites with a non-mammalian Odyssey Blocker (LI-COR Biosciences, Lincoln, NE) for 45 minutes at RT. Blots were then incubated with α 2 δ 3 antibodies (see Table 1 IRDye 680RD (LI-COR) diluted 1:10,000, for 1 hour at RT. The blots were washed and immediately imaged and evaluated using the LI-COR Odyssey ® Infrared Imaging System.
Measurements of distances:
The linear distance of α 2 δ 3 immunoreactive puncta to the closest labeled bipolar and horizontal cell tip, and photoreceptor terminal was measured using Zeiss 
Results
The α 2 δ subunits are a group of auxiliary calcium channel subunits that modify the properties of the α1 pore-forming and sensor subunit (Davies et al. 2007) . In this study, we report the expression and localization of the α 2 δ 3 subunit in the mouse and rat retina.
Presence of α 2 δ 3 mRNA: From mouse and rat retinal and brain extracts, RT-PCR (n=5 retinas) yielded a strong single band at ~305 bp corresponding to the predicted size of the α 2 δ 3 subunit fragment. As a control experiment, water was used in place of template DNA, and no DNA amplification was observed (Fig. 1A) . These findings indicate the presence of α 2 δ 3 mRNAs in the retina and brain.
Specificity and characterization of the α 2 δ 3 subunit antibody
Then, we performed Western blots to determine the presence of the α 2 δ 3 subunit protein in the retina. Since α 2 δ 3 mRNA is reported in multiple regions of the mouse CNS (Angelotti and Hofmann, 1996; Klugbauer et al., 1999; Gong et al., 2001) , the brain was used as a positive control for our Western blots. Western blotting of mouse (n=6 retinas) and rat retina (n=4 retinas) and brain homogenates showed one labeled band corresponded to a molecular weight of ~123 kDa in membrane fractions of mouse and rat brain and retina (Fig. 1B) .
Immunohistochemical localization of α 2 δ 3 subunit in rodent retinae α 2 δ 3 subunit immunoreactivity was present in cell bodies in the GCL ( Fig. 2A, C ; arrowheads) and INL ( Fig. 2A, C ; arrows), and there was weak immunostained processes in the IPL, and strong immunostained puncta in the OPL. The α 2 δ 3 subunit immunostaining pattern was similar for both rat ( Fig. 2A) and mouse (Fig. 2C) Specificity of the antibody was demonstrated by the absence of immunostaining in sections incubated with antibodies preabsorbed with the immunization peptide (Fig. 2B, D) .
Identification of α 2 δ 3 -immunoreactive ganglion and amacrine cells
To characterize the α 2 δ 3 -expressing cell bodies in the GCL, we immunostained whole-mount retinas from rats (n=7 retinas) and mice (n=5 retinas). The α 2 δ 3 subunit immunostaining revealed cell bodies with somal diameters that varied from 7 to 25 µm in the rat ( Fig. 3A ; n=7 retinas) and mouse ( Fig. 3D; n=5 retinas To test if the α 2 δ 3 -expressing cells in the GCL are RGCs, whole-mounted rat (n=6 retinas) and mouse (n=3 retinas) retinas were immunostained with α 2 δ 3 subunit and RBPMS antibodies.
RBPMS is a selective marker of all RGCs in rat and mouse retina (Kwong et al., 2010; Rodriguez et al., 2014) . All RBPMS-immunoreactive cells contained α 2 δ 3 subunit immunoreactivity, indicating that RGCs express this auxiliary Ca subunit in rat (Fig. 3A-C) and mouse ( Fig. 3D-F ). In addition, many of the small diameter α 2 δ 3 -immunoreactive cells in the GCL were not RBPMS immunoreactive (Fig. 3C , F, arrows) suggesting they are displaced amacrine cells (Jeon et al., 1998; Pérez de Sevilla Müller et al., 2007; Lin and Masland, 2006; Perry and Walker, 1980; Perry, 1981) .
Amacrine cells are composed of multiple types and most express either GABA or glycine immunoreactivity (Wässle and Boycott, 1991; Kay et al., 2011) . Vertical sections were stained with antibodies to the glutamic acid decarboxylase 67 isoform (GAD 67 ), a GABA synthesizing enzyme (Schnitzer and Rusoff, 1984) . Numerous somata in the GCL and the proximal INL were GAD 67 immunoreactive in both rat (Fig. 4B ) and mouse (Fig. 4E) retina. In the rat retina, ~23%
of the GAD 67 immunostained cells contained α 2 δ 3 subunit immunoreactivity in the GCL and in the mouse retina ~42% of the GAD 67 immunostained cells contained α 2 δ 3 subunit immunoreactivity in the GCL (arrowheads). In addition, ~59% and 50% of GAD 67
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immunostained cell bodies in the GCL did not contain α 2 δ 3 subunit immunoreactivity (arrows) in rat and mouse, respectively suggesting the presence of displaced amacrine cells that do not express the α 2 δ 3 subunit.
In summary, these findings indicate that α 2 δ 3 subunit immunoreactive cells in the GCL are expressed by all RGCs and some displaced amacrine cells.
Characterization of α 2 δ 3 -immunoreactive cell bodies in the INL
The common amacrine cell markers, GABA and glycine, and the bipolar cell and Müller cell marker, Chx10 were used to determine whether the α 2 δ 3 -expressing cell bodies in the INL are expressed by amacrine and bipolar cells. In the rat retina, ~60% of the α 2 δ 3 subunit immunoreactivity cells contained GAD 67 in the INL ( ( Fig. 5D -F, arrows) and mouse ( Fig. 6D-F , arrows) retina. These findings are consistent with earlier in situ hybridization histochemical findings (Nakajima et al. 2009 ), which report α 2 δ 3 subunit mRNAs in mouse bipolar cells. In addition, double immunostaining studies with the antibodies to the α 2 δ 3 subunit and PKCα, a marker for rod bipolar cells and DA amacrine cells (Negishi et al., 1998; Haverkamp and Wässle, 2000) revealed α 2 δ 3 -immunoreactive cell bodies with PKCα immunoreactivity in rat (Fig. 5G-I , arrows) and mouse ( Fig. 6G-I, arrows) retina.
In summary, these findings indicate a differential expression of the α 2 δ 3 subunit in glycine-and GABA-immunoreactive amacrine cells, and the expression of the α 2 δ 3 subunit in most bipolar cells in the rodent retina.
Expression of the α 2 δ 3 subunit puncta in the mouse outer retina
To evaluate the localization of the α 2 δ 3 subunit in the OPL, we performed double-labeling experiments with specific neuronal markers for bipolar and horizontal cells, and photoreceptors in mouse retina.
The localization of the α 2 δ 3 subunit to bipolar cell dendrites was tested by double immunostaining studies with an antibody to PKCα (Fig. 6G-I, arrowheads) , to mGluR6, which is localized to the tips of ON-bipolar cell dendrites (tom Dieck et al., 2012; Fig. 7A-D) and to Goα, a marker for ON bipolar cells (Vardi, 1998; Haverkamp and Wässle, 2000; Fig. 7E-H) . The α 2 δ 3 subunit puncta were adjacent to the bipolar cell tips without any overlap in single sections, suggesting they are not located on the distal dendrites of ON bipolar cells. Most α 2 δ 3 subunit puncta were located greater than 0.24±0.09 µm from the nearest ON bipolar cell tip.
To test if α 2 δ 3 subunit immunoreactivity is localized to horizontal cells, retinal sections were double immunostained with antibodies to the α 2 δ 3 subunit, and to calbindin, a specific horizontal cell marker (Röhrenbeck et al., 1987; Chun and Wässle, 1993; Massey and Mills, 1996; Haverkamp and Wässle, 2000; Hirano et al., 2005) and to VGAT, which is mainly located to horizontal cell endings (Cueva et al., 2002; Guo et al., 2010; Lee and Brecha, 2010) . α 2 δ 3 immunoreactive puncta were found in the OPL adjacent to horizontal cell processes indicating that they are not expressed by horizontal cells ( Fig. 8A-D; Fig. 8E-H ). In addition, double To test if α 2 δ 3 subunit immunoreactivity is localized to photoreceptor terminals, retinal sections were double stained with antibodies to the α 2 δ 3 subunit and FITC-peanut agglutinin (PNA), a specific marker for mouse cone pedicle bases (Blanks and Johnson, 1983) . Single scan immunohistochemical analysis revealed that the α 2 δ 3 subunit is not located at PNA-labeled cone pedicles ( Figure 9A-D) . The average distance between the closest α 2 δ 3 subunit and the PNAlabeled cone pedicle was 1.4±0.2 µm.
Double label studies with antibodies to Bassoon and to CtBP2, which are presynaptic proteins associated with the synaptic ribbon in both rod spherules and cone pedicles (Schmitz et al., 2000; Brandstätter et al., 1999) were used to determine if this subunit is expressed at or near photoreceptor ribbons. Some α 2 δ 3 and Bassoon immunoreactive profiles ( Fig. 9E-H, arrowheads) overlapped, however, the majority of the α 2 δ 3 immunostained puncta were adjacent to Bassoon immunostained puncta, which are located at the base of the synaptic ribbon (Brandstätter et al.,1999) (Fig. 9E-H, arrows) . α 2 δ 3 immunoreactive puncta were also adjacent or overlapping with CtBP2-immunoreactivity in photoreceptors (Fig. 9I-L, arrows) .
Finally, double label studies with antibodies to PSD-95, which is located in the plasma membrane of rod and cone photoreceptor terminals (Koulen et al., 1998; Pérez de Sevilla Müller et al., 2013) and the vesicular glutamate transporter 1 (VGluT1), which is expressed highly in photoreceptor terminals (Johnson et al., 2003; Sherry et al., 2003) were also used to determine if α 2 δ 3 subunit immunoreactivity is located at photoreceptor terminals. Single scans of the α 2 δ 3 subunit and PSD-95 immunostaining (Fig. 10A-D) and VGluT1 ( Fig. 10E-H) showed that PSD-95 and VGluT1 immunoreactive photoreceptor terminals contain all the α 2 δ 3 immunoreactive puncta, indicating that the α 2 δ 3 puncta in the OPL is located in rod and cone photoreceptor terminals. Together these findings suggest that α 2 δ 3 subunits are located at or near the photoreceptor ribbon (see Discussion).
Discussion
The presence of α 2 δ 1 (Huang et al., 2013) and α 2 δ 4 (Ruether et al., 2000; Wycisk et al., 2006a,b; Mercer et al, 2011; Pérez de Sevilla Müller et al., 2013; Mercer and Thoreson, 2013 ) Ca channel subunits have been reported in the retina. This study extends these earlier findings and reports the expression of the α 2 δ 3 subunit by multiple retinal cell types in the mouse and rat retina. The α 2 δ 3 subunit is localized to all RGCs, some displaced amacrine and amacrine cells, rod and cone bipolar cells, and photoreceptors. We did not observe α 2 δ 3 subunit immunoreactivity in horizontal cells. Although horizontal cells are the only group of retinal neurons that do not express α 2 δ 3 subunits, they do express other calcium channel subunits, including α1C (L-type Ca channel), α1B (N-type Ca channel) and α1A (P/Q-types) subunits (Ueda et al. 1992; Löhrke & Hofmann, 1994; Schubert et al. 2006; Witkovsky et al. 2006; Xue et al., 2013) and the α 2 δ 1 subunit (Huang et al., 2013) . These subunits are apparently sufficient for mediating calcium channel function in horizontal cells.
α 2 δ 3 subunit expression
The α 2 δ 3 subunit was initially reported in the brain (Angelotti and Hofmann, 1996; Klugbauer et al., 1999; Gao et al., 2000) and α 2 δ 3 subunit mRNA was subsequently reported in mouse retinal bipolar cells by in situ hybridization histochemistry (Nakajima et al., 2009) . Our findings are consistent with Nakajima's report and extend this observation by showing α 2 δ 3 subunit immunoreactivity in RGCs, amacrine cells and photoreceptors.
Possible functional roles of the α 2 δ 3 subunit in retinal cells
A well-established role for auxiliary Ca channel subunits is the assembly and trafficking of the α1 pore-forming subunits to the plasma membrane (Arikkath and Campbell, 2003) . α 2 δ subunits also participate in synaptogenesis and cytoskeleton formation (Eroglu et al., 2009; Kurshan et al., 2009 ). Furthermore, the α 2 δ 3 subunit participates in presynaptic organization and synaptic transmission at the Drosophila neuromuscular junction (Dickman et al., 2008; Kurshan et al., 2009 ). In the retina, α 2 δ 3 subunits could therefore have multiple roles including (1) regulating the trafficking of the α1 subunit from the soma to the dendritic and axonal endings (Dickman et al., 2008) , (2) increasing exocytosis at the presynaptic terminal when Ca 2+ influx is decreased 20 (Hoppa et al., 2012) and (3) modifying the biophysical properties of the L-type Ca channels to influence the release of glutamate from photoreceptors and bipolar cells (Heidelberger et al., 2005) .
Our study shows that α 2 δ 3 subunit is primarily expressed in retinal cell bodies in the rodent retina. Similar immunostaining has been reported for the α 2 δ 1 subunit (Huang et al., 2013) which is a neuronal thrombospondin receptor (Eroglu et al., 2009) 
α 2 δ 3 subunit in retinal diseases
Mice lacking or having mutations of the α 2 δ subunits are characterized by multiple physiological defects, including neurodegeneration, epilepsy, neuropathic pain, cardiovascular dysfunction, and alterations of the biophysical properties of L-type Ca 2+ currents in cardiomyocytes (Snell, 1955; Fuller-Bicer et al., 2009; Neely et al., 2010) . Therefore, it is not surprising that a mutation visual system deficits with a mutation or deletion of the α 2 δ 3 subunit. However, this suggestion is highly speculative because the structure and electrophysiological properties of Cacna2d3 null mutant retinas have not been evaluated and it is unknown if there are structural or functional alterations in the retina. Further investigation of the Cacna2d3 null mouse line (Neely et al., 2010 ) is needed for delineating the functional role of the α 2 δ 3 subunit in the retina.
Expression of the α 2 δ 3 subunit is altered in different diseases. For instance, there is a down regulation of α 2 δ 2 subunit expression in most non-small cell lung cancer cell lines (Carboni et al., 2003) . Furthermore, previous studies have shown that Cacna2d3 as a reliable marker for malignant childhood neuroblastomas (Thorell et al., 2009; Chu and Best, 2003; Howarth et al., 2012) . There is also an up regulation of α 2 δ 1 expression in rat spinal dorsal horn and dorsal root ganglia following peripheral nerve injury (Luo et al., 2001; Newton et al., 2001) . In generalized progressive retinal atrophy models, where photoreceptor death leads to blindness, current experimental findings indicate that Cacna2d3 mRNA levels are unaltered (Lippmann et al., 2007) , which suggests that the α 2 δ 3 subunit is a poor marker for retinal disease.
In conclusion, the α 2 δ 3 subunit could be involved in transmitter release in ganglion, amacrine, bipolar cells and photoreceptors, as well as trafficking and stabilization of the corresponding α1
calcium channel subunit to their presynaptic sites. 
